Latest news with #MVE
Yahoo
08-07-2025
- Business
- Yahoo
Cryoport's MVE Biological Solutions Introduces Next Generation Vapor Shippers
New SC vapor shipper series improves reliability through extended hold times and patented impact-absorbing and Vapor Shield Technology NASHVILLE, Tenn., July 8, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences, today announced the launch of MVE Biological Solutions' new vapor shippers, the SC 4/2V and SC 4/3V, offering medical and animal health professionals, laboratories, researchers, hospitals and clinics, pharmaceutical companies, and others dramatically improved safety and reliability for transporting and preserving sensitive biological materials at cryogenic temperatures. Built on MVE's legacy SC 4/2V and 4/3V vapor shipper platform, the next-generation SC 4/2V and 4/3V models have been redesigned utilizing innovative technologies to offer customers added protection during extended or challenging shipments. These four-liter vapor shippers are engineered to safely transport critical biological materials such as cells and tissues materials for cell therapies, biopharma, reproductive health materials, and animal health materials, including vaccines, while maintaining the materials' integrity throughout the journey. The new SC 4/2V and SC 4/3V vapor shipper models include several key advancements designed to enhance performance and reliability. Hold times for both next-generation models have been significantly extended to up to 19 days for the SC 4/2V (previously 13 days) and 26 days for the SC 4/3V (up from 21 days) which provides greater flexibility and security during transit delays. MVE's patented BEND DON'T BREAK™ technology features a specially designed top that flexes under stress, absorbing impact to reduce the risk of damage during rough handling that sometimes happens during shipping. "At MVE, we are committed to continuously refining our products to meet the evolving demands of our customers," said Mike Duich, President and CEO of MVE Biological Solutions. "The new SC 4/2V and 4/3V vapor shippers, built on our proven and trusted platform, are now strengthened with longer hold times, reduced refill frequency and lower operating costs. Additional features of our patent-pending technology also protect against vacuum degradation and absorbs shocks, with the ultimate goal of reducing damage-related failures and costly re-shipments. These enhancements reflect our broader mission to support scientific progress with robust, dependable, and cost-efficient cryogenic systems." Jerrell Shelton, CEO of Cryoport added, "these advances in the SC series of our patented vapor shippers are a part of our ongoing efforts to continually improve our products and services that support our advanced temperature-controlled supply chain solutions for the life sciences. By providing longer temperature hold times, better protection against sudden shock along with additional security features, we have further reduced the supply chain risks for highly valued temperature sensitive life sciences materials which helps with the advancement of the life sciences industry." Other upgraded features of the new vapor shippers include a newly integrated lid locking tab which helps prevent breakage, along with MVE's patent-pending Vapor Shield Technology, which minimizes the risk of vacuum loss caused by liquid nitrogen overfilling. These enhancements work together to provide greater reliability and "peace of mind" when transporting critical biological materials. For more information on the SC 4/2V and SC 4/3V vapor shippers, please visit About Cryoport, IncCryoport, Inc. (Nasdaq: CYRX), is a global leader in temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. We support biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products designed to minimize risk and maximize reliability across the temperature-controlled supply chain for the Life Sciences. Our integrated supply chain platform includes the Cryoportal® Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems, which in varying combinations deliver end-to-end solutions that meet the rigorous demands of the life sciences. With innovation, regulatory compliance, and agility at our core, we are "Enabling the Future of Medicine™." Our corporate headquarters, located in Nashville, Tennessee, is complemented by global sites in the Americas, EMEA, and APAC. For more information, visit or follow via LinkedIn at or @cryoport on X, formerly known as Twitter at for live updates. Forward-Looking StatementsStatements in this press release which are not purely historical, including statements regarding Cryoport's intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, those related to MVE Biological Solutions' SC 4/2V and SC 4/3V shippers, including their potential impact on future revenue and revenue streams. It is important to note that Cryoport's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic and geopolitical conditions, supply chain constraints, inflationary pressures, the effects of foreign currency fluctuations, trends in the products markets, variations in Cryoport's cash flow, market acceptance risks, and technical development risks. Cryoport's business could be affected by other factors discussed in Cryoport's SEC reports, including in the "Risk Factors" section of its most recently filed periodic reports on Form 10-K and Form 10-Q, as well as in its subsequent filings with the SEC. The forward-looking statements contained in this press release speak only as of the date hereof and Cryoport cautions investors not to place undue reliance on these forward-looking statements. Except as required by law, Cryoport disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release. View original content to download multimedia: SOURCE Cryoport, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
08-07-2025
- Business
- Yahoo
EXCLUSIVE: Cryoport Boosts Cold Chain Tech With New Shippers Designed For Delays And Rough Handling
Cryoport (NASDAQ:CYRX) on Tuesday announced the launch of MVE Biological Solutions' new vapor shippers, the SC 4/2V and SC 4/3V. The company said these shippers offer medical and animal health professionals, laboratories, researchers, hospitals and clinics, pharmaceutical companies, and others dramatically improved safety and reliability for transporting and preserving sensitive biological materials at cryogenic temperatures. Built on MVE's legacy SC 4/2V and 4/3V vapor shipper platform, the next-generation SC 4/2V and 4/3V models have been redesigned utilizing innovative technologies to offer customers added protection during extended or challenging four-liter vapor shippers are engineered to safely transport critical biological materials such as cells and tissue for cell therapies, biopharma, reproductive health materials, and animal health materials, including vaccines while maintaining the materials' integrity throughout the journey. According to the company, the new SC 4/2V and SC 4/3V vapor shipper models include several key advancements designed to enhance performance and reliability. Hold times for both next-generation models have been significantly extended to 19 days for the SC 4/2V (previously 13 days) and 26 days for the SC 4/3V (up from 21 days), providing greater flexibility and security during transit delays, the company claims. MVE's patented 'BEND DON'T BREAK' technology features a specially designed top that flexes under stress, absorbing impact to reduce the risk of damage during rough handling that sometimes happens during shipping. Other upgraded features of the new vapor shippers include a newly integrated lid-locking tab that helps prevent breakage and MVE's patent-pending 'Vapor Shield Technology,' which minimizes the risk of vacuum loss caused by liquid nitrogen overfilling. In May, CryoPort reported first-quarter revenue growth of 10.1% to $41.04 million, missing the analyst consensus estimate of $44.69 million. The company reduced its quarterly net loss to $14.0 million, or 28 cents per share, down from $20.9 million, or 43 cents per share, a year ago. The company lowered its fiscal 2025 sales outlook from $240.00 million to $250.00 million to $165.00 million to $172.00 million, compared to the $186.04 million estimate. CryoPort stock lost close to 9% in value year-to-date. Price Action: CYRX stock closed lower by 4.83% at $7.290 on Monday. Photo by MacroEcon via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? CRYOPORT (CYRX): Free Stock Analysis Report This article EXCLUSIVE: Cryoport Boosts Cold Chain Tech With New Shippers Designed For Delays And Rough Handling originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
15-06-2025
- Health
- Yahoo
Aussie grey nomads, campers warned as deadly threat prompts new campaign
Australians are being urged to take mosquito-borne diseases seriously, as a new government initiative rolls out free repellent dispensers across high-risk regions. The pilot program, launched in memory of Peter Blackaby — who tragically died from Murray Valley encephalitis (MVE) in 2023 — is part of Western Australia Health's intensified Fight the Bite campaign. Peter's wife, Sonia, is now warning others not to take mosquito bites lightly. "Not enough people are aware of the severity of the viruses that mozzies carry," Sonia told Yahoo News. "Most people have never even heard of MVE. We hadn't. Awareness is the only way to start imprinting the message with people: Prevent bites. It's the only way to protect yourself." The couple had made regular caravanning trips through the Kimberley, Pilbara, and Gascoyne areas, now included in the free repellent dispenser trial. "We had made many trips to Broome, the Dampier Peninsula, Kununurra and the Gibb River Road," Sonia said. "It was one of our favourite destinations." During their final three-week trip together, there were no warning signs. "Pete never said mosquitoes really bothered him. There wasn't a particular bite on him that we were aware of," she said. "I always get smashed by mosquitoes, though." Tragically, Peter contracted MVE — a rare but potentially fatal virus carried by mosquitoes — and lost his life not long after. Since 2023, there have been 12 recorded cases of MVE in WA, resulting in five deaths. The new initiative will see free mosquito repellent dispensers made available to eligible community organisations in high-risk areas, such as caravan parks, sporting clubs, outdoor cinemas and alfresco venues. It is timed to coincide with the annual "grey nomad" season, when thousands of older travellers head north during the winter months — a group considered particularly vulnerable to mosquito-borne illness. A State-wide rollout is planned for 2026, following the initial trial across the Kimberley, Pilbara and Gascoyne. WA Health continues to detect MVE activity through its mosquito and sentinel chicken surveillance programs. Although winter is usually a lower-risk period, 2025 has been an unusual year, prompting authorities to reinforce prevention messages. A WA Health spokesperson told Yahoo that the northern dry season, which generally represents a lower risk period for mosquito-borne viruses, has been an unusual year in 2025. "Whilst rare, infection can cause a very serious, potentially fatal, disease. Individuals who survive are often left with severe neurological deficits or disability," they said. "Residents and travellers heading north need to take extra precautions to prevent mosquito bites by wearing long, loose-fitting, light-coloured clothing, avoid areas where mosquitoes are in high numbers and apply an effective insect repellent to all areas of exposed skin. 🦠 Family's Bali nightmare amid disease outbreak in tourist hotspots ‼️ Scientists use toxins to kill off world's most dangerous creature 🦟 Could this tiny gadget reduce itch caused by mosquito bites? "WA Health is also encouraging local governments and larger businesses/corporate organisations to make insect repellent readily accessible to the public and employees in high-risk locations, to reduce the risk of mosquito-borne disease. A limited number of repellent dispensers are available, free of charge, to eligible community groups/organisations in Kimberley, Pilbara, and Gascoyne to participate in this important Fight the Bite initiative. Sonia, meanwhile, hopes sharing her family's story can help save others. "Prevent bites — it's the only way," she said. Love Australia's weird and wonderful environment? 🐊🦘😳 Get our new newsletter showcasing the week's best stories.
West Australian
12-06-2025
- Health
- West Australian
WA's new free mosquito repellent initiative dedicated to man who died after contracting MVE in Broome
The WA Government's new free mosquito-fighting repellent dispenser initiative has been dedicated to Peter Blackaby, who lost his life after contracting Murray Valley encephalitis in Broome in May 2023. Sonia Blackaby said she and her late husband Peter, from Newman, had been travelling with their caravan and had stopped in Broome for about three weeks when Mr Blackaby contracted the fatal virus. 'After we returned home, within a matter of probably 48 hours, he went from showing signs to being in a coma and eventually developing brain damage,' Ms Blackaby said. 'We spent five weeks in the intensive care unit and he never recovered. I never spoke to my husband again.' Since the tragedy, Ms Blackaby has been raising awareness about how deadly the disease can be and urging her local and State Governments to make information on MVE more readily available. 'A lot of people don't realise how serious it is,' she said. 'Mosquitoes aren't just annoying; they carry viruses that kill, and MVE has no cure, no treatment and no vaccine. If it doesn't kill you, it can cause severe, irreversible brain damage. 'The only way to prevent it is to not get bitten.' The pilot of the new initiative will provide free mosquito repellent dispensers to community groups across the Kimberley, Pilbara, and Gascoyne regions in an effort to protect communities from serious and potentially fatal mosquito-borne diseases like MVE. Eligible community organisations such as sporting clubs, caravan parks, outdoor cinemas, and alfresco venues are being encouraged to take advantage and apply for a free dispenser According to the Government, there have been 12 cases of MVE in WA since 2023, resulting in five deaths. Health Minister Meredith Hammat said the initiative, in conjunction with the Government's Fight the Bite campaign, was raising awareness of the potential threats of mosquito bites. 'Murray Valley encephalitis is a rare but potentially fatal disease, and this initiative ensures Peter's story continues to make a difference,' she said. 'The Fight the Bite campaign is raising awareness through real stories affecting everyday Western Australians, and I encourage everyone to take action against mosquito bites.' The Government said it was launching the initiative in time for the 'grey nomad' travel season — when older travellers, who are at greater risk of acquiring a mosquito-borne disease, head north during winter. Preventative Health Minister Sabine Winton said mosquito-borne diseases could have lifelong effects, and it was important to prioritise prevention. 'This program provides mosquito repellent in key locations where the risk of mosquito bites is highest, helping communities stay protected,' she said. While the northern dry season generally decreases the chances of contracting mosquito-borne diseases, the Department of Health's mosquito and sentinel chicken surveillance programs have continued to detect MVE activity during this year's dry. Residents and travellers heading north need to continue to take extra precautions to avoid mosquito bites by wearing long, loose-fitting, light-coloured clothing, and applying an effective insect repellent. A State-wide rollout of the initiative is expected in 2026.
